Sascha Pilemann-Lyberg

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes

Sascha Pilemann-Lyberg, Tine W. Hansen, Nete Tofte et al. · Diabetes Care · 2019 · 73 citations · Full text

Medicine, Nephrology, Renal Pathology +16

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol—Rationale, Design, and Baseline Data

Maryam Afkarian, Sarit Polsky, Maria Luiza Caramori et al. · Diabetes Care · 2019 · 48 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes

Sascha Pilemann-Lyberg, Daniel Guldager Kring Rasmussen, Tine W. Hansen et al. · Diabetes Care · 2019 · 46 citations · Full text

Medicine, Nephrology, Pathology +17

Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes

Sascha Pilemann-Lyberg, Tine W. Hansen, Frederik Persson et al. · Nephrology Dialysis Transplantation · 2018 · 23 citations

Medicine, Endocrinology, Internal Medicine +17